Biogen Idec Inc. (BIIB) Chief Executive George Scangos is trying to solve a problem of his own creation: He must replenish an early-stage drug research pipeline that he decimated after taking over the biotechnology company in 2010.
Biogen Idec Inc. (BIIB) Chief Executive George Scangos is trying to solve a problem of his own creation: He must replenish an early-stage drug research pipeline that he decimated after taking over the biotechnology company in 2010.
